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Among proteases, metalloproteases are implicated in tissue remod-
eling, as shown in numerous diseases including allergy. ADAMs (A
Disintegrin And Metalloprotease) metalloproteases are implicated
in physiologic processes such as cytokine and growth factor shed-
ding, cellmigration, adhesion, or repulsion. Our aimwas tomeasure
ADAM-12 expression in airway epithelium and to define its role
during the allergic response. To raise this question, we analyzed the
ADAM-12 expression ex vivo after allergen exposure in patients with
allergic rhinitis and in vitro in cultured primary human airway
epithelial cells (AEC). Clones of BEAS-2B cells transfected with the
full-length form of ADAM-12 were generated to study the conse-
quences of ADAM-12 up-regulation on AEC function. After allergen
challenge, a strong increase of ADAM-12 expression was observed
in airway epithelium from patients with allergic rhinitis but not
from control subjects. In contrast with the other HB-epidermal
growth factor sheddases, ADAM-10 and -17, TNF-a in vitro in-
creased the expression of ADAM-12 by AEC, an effect amplified by
IL-4 and IL-13. Up-regulation of ADAM-12 in AEC increased the
expression of a3 and a4 integrins and to the modulation of cell
migration on fibronectin but not on collagen. Moreover, over-
expression of ADAM-12 in BEAS-2B enhanced the secretion of
CXCL1 and CXCL8 and their capacity to recruit neutrophils. CD47
was strongly decreased by ADAM-12 overexpression, a process
associated with a reduced adhesion of neutrophils. These effects
were mainly dependent on epidermal growth factor receptor
activation. In summary, ADAM-12 is produced during allergic
reaction by AEC and might increase neutrophil recruitment within
airway mucosa.
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Allergic diseases, including asthma and allergic rhinitis, are
chronic respiratory diseases characterized by a predominant T
helper cell type 2 (Th2) inflammation, airway hyperresponsive-
ness, and airflow obstruction. At the beginning of the disease,
these symptomsare reversible, butmaybecome irreversiblewhen
the disease progresses as airways remodeling develops. Histo-
logic studies have described that patients with asthma display
airway wall abnormalities mainly consisting in an increase in
smooth muscle mass, mucus gland hypertrophy, extracellular
matrix changes (i.e., collagen deposition), and inflammatory cell
infiltration mainly composed of eosinophils, T lymphocytes, and
mast cells (1). In severe asthma, an influx of neutrophils in the
airways has also been observed (2). The exaggerated decrease in
forced expiratory volume at the first second (FEV1) in patients
with chronic asthma is generally considered to be at least in part
due to these airway structural changes. Although less obvious,
structural changes are also present in allergic rhinitis and
frequently associated with the recruitment of neutrophils (3).
Matrix metalloproteases (MMPs) are implicated in tissue
remodeling, as shown in numerous diseases, including allergy.
Indeed,MMP-2, -3, -9, -12 have been implicated in different steps
of the disease (4–7). Other members of the vast zinc proteases
family, the ADAM (ADisintegrin AndMetalloprotease), which
are eithermembrane-anchoredor secretedmetalloproteases, and
the ADAMTS (ADAM with ThromboSpondin motifs), have
emerged as asthma associated genes. Indeed, ADAM-33 poly-
morphism was identified as a gene associated with bronchial
hyperresponsiveness in humans (8), and ADAM-8 up-regulation
was reported in a murine model of allergic asthma by microarray
analysis (9). More recently, Paulissen and coworkers (10) ob-
served an increased expression ofADAM-8, -9, and -12mRNA in
induced sputum from patients with asthma as compared with
control subjects while, on the contrary, ADAMTS-1 and -15
mRNA levels were decreased.
Proteases belonging to the ADAM family share a highly
conserved domain structure: an N-terminal secretion signal,
a prodomain, a metalloprotease domain, a disintegrin domain,
a cystein-rich region followed by an epidermal growth factor
(EGF) repeat, and a transmembrane domain ended by a cyto-
plasmic tail. ADAMs are implicated in physiologic processes
such as cytokine and growth factor shedding, cell migration, cell
adhesion, or repulsion (11, 12). These properties explain their
CLINICAL RELEVANCE
A Disintegrin And Metalloprotease (ADAM)-12 is a met-
alloprotease that possesses an important sheddase activity.
ADAM-12 up-regulation during allergic airway diseases
and its implication in the control of neutrophil recruitment
by airway epithelial cells suggest its involvement in the
control of airway inflammation.
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involvement in complex events such as myogenesis or fertiliza-
tion, and suggest a role in inflammatory and immune reactions.
ADAM-12 encodes two different forms: a membrane-bound
(long) form, ADAM-12L, and an alternatively spliced secreted
form, ADAM-12S (13). Previous reports showed that ADAM-12
supports cell attachment through its interaction with integrins
(a3, a4, and a5) and with syndecan-4 (14–16). Moreover,
ADAM-12 is also implicated in the transactivation of epidermal
growth factor receptor (EGFR) through the shedding of ligands
such as HB-EGF (17, 18), although ADAM-10 and ADAM-17
also play important roles in this process (19). ADAM-12 is
expressed in high amounts in tissues characterized by rapid
growth, including tumors and human placenta (13, 20–22).
In preliminary experiments using a microarray-based ap-
proach, we identified thatADAM-12 is up-regulated in bronchial
epithelial cells activated by a proinflammatory mediator such as
TNF-a. Since allergic reaction is associated with the production
of proinflammatory cytokines (23, 24), we hypothesized that the
expression ofADAM-12might be increased in airway epithelium
during the allergic response and might participate in the modu-
lation of inflammatory reaction and tissue remodeling. To raise
this question, we first analyzed the expression of this metal-
loprotease ex vivo in patients with allergic rhinitis exposed to
allergens and in vitro in human airway epithelial cells. We also
defined the consequences of ADAM-12 up-regulation on airway
epithelial cell (AEC) behavior by generating clones of BEAS-2B
cells transfected with ADAM-12L. Our data show that ADAM-12
expression is increased after allergen exposure in allergic patients
and by TNF-a stimulation in AEC. Moreover, ADAM-12
overexpression in AEC is associated with modifications of cell
adhesion, integrin expression, and cytokine production through
the activation of EGFR. This process might be responsible for
modifications of the interactions between AEC and neutrophils
associated with allergic diseases.
MATERIALS AND METHODS
Immunohistochemistry on Nasal Biopsies Sections
Nasal biopsies were obtained from three patients with allergic rhinitis
with a history of house dust mite perennial rhinitis and a positive prick
test to theantigen extract, and fromthreehealthy subjects.Nasal biopsies
were performed in turbinates at baseline (at distance from any symp-
toms) and 24 hours after an allergen provocation with 100 IR Dpt
allergen as described elsewhere (2). Every patient with allergic rhinitis
presented after allergen challenge an early and a late reaction as defined
by the clinical score (25) associatedwith an inflammatory infiltratewithin
the nasal mucosa, whereas no obvious reaction or influx was detected in
control subjects. These procedures were reviewed and approved by the
Hospital InstitutionalReviewBoard, andawritten informedconsentwas
obtained from all subjects included in the study.
Immunohistochemistry analysis for ADAM-12 was performed on
paraffin-embedded sections. First, sections were deparaffinized and
treated for Ag retrieval by incubation at 908C for 20 minutes in citrate
buffer (10 mM, pH 6). Sections were then incubated with goat IgG anti–
ADAM-12 (N-terminal domain) antibody (Abcam, Paisley, UK) at the
concentration of 2 mg/ml in PBS with 2% AB1 normal human serum.
After washings, the bindingwas detected by incubationwith biotinylated
anti-goat IgG and then with the ABC-alkaline phosphatase kit (Vector,
Burlingame, CA). Enzymatic activity was revealed in red with Fast Red
and sections were counterstained with hematoxylin (Sigma-Aldrich, St.
Louis, MO). The number of epithelial cells positive for ADAM-12 was
quantified in the epithelial layers from all the samples. Measurements
were performed by two independent observers and the coefficient of
variation among them was below 10%.
Cell Culture, Stable Transfection, and Treatments
Primary cultures of human Airway Epithelial Cells (AEC) were gener-
ated by culturing human bronchial epithelial explants as described
previously (26). Briefly, human bronchial epithelial biopsies were
obtained by fiberoptic bronchoscopy from patients who were being
investigated for chronic cough or cancer. Biopsies were taken largely at
distance from all lesions. Histologic features of the bronchial mucosa
werenormal inall specimens.Explants (z 0.53 0.5mmin size)wereplaced
onto a well of a 6-well plate culture plastic dishes coated with collagen G
matrix (type I and III collagen; BiochromKG, Berlin, Germany). After an
adherence phase, explants were cultured in DMEM/F12 medium (Gibco,
Paisley, UK) containing 1% Ticarpen (GlaxoSmithKline, Marly-le-Roi,
France), 2 mM L-Glutamine, 2% Ultroser G, and 2.5 mg/ml Fungizone
(Invitrogen, Paisley, UK) until AEC were confluent. Then, explants were
removedand confluent epithelial cellswere incubatedwith 20 ng/mlTNF-a
or in culture medium alone as control.
All procedures were reviewed and approved by Hospital Institu-
tional Review Board, and a written informed consent was obtained
from all subjects included in the study.
Human BEAS-2B cells were obtained from American Type Culture
Collection (Manassas, VA). As described elsewhere (18), BEAS-2B
cells which spontaneously express very low amounts of ADAM-12L
were stably transfected with pcDNA3-neo plasmid encoding human
ADAM-12L cDNA, kindly provided by Dr. Ulla Wewer (Copenhagen,
Denmark). Cells were grown in Airway Epithelial Cell Basal Medi-
um supplemented with Supplement Pack (Promocell, Heidelberg,
Germany) in presence of 0.1 mg/ml G418 (Invitrogen) for stable
transfectants. AEC, BEAS-2B cells and ADAM-12 transfected clones
were starved in Airway Epithelial Cell Basal Medium with 0.1% BSA
deprived of Supplement Pack overnight before each experiment and
then stimulated or not with 5, 20 or 50 ng/ml TNFa (Peprotech, Rocky
Hill, NJ), IL-4 (Promocell), IL-13 (Peprotech) or culture medium alone
as control for 1, 2, 6, 8, 12, or 24 hours depending on the experiment. In
some experiments, the effect of rh-EGF (10 ng/ml; Promocell) and of the
inhibitor of EGFR activator AG1478 (15 nM; Calbiochem, VWR
International, Darmstadt, Germany) was also evaluated.
Neutrophil Isolation
Neutrophils were isolated from the peripheral venous blood of healthy
human volunteers. First, peripheral blood mononuclear cell (PBMC)
layers prepared by density centrifugation on Ficoll-Paque (Amersham
Biosciences, Uppsala, Sweden) were discarded. Then the polymorpho-
nuclear neutrophil (PMN) layer was removed and remaining eryth-
rocytes were eliminated with lysis buffer by hemolysis (LBH, 155 mM
NH4Cl, 10 mM KHCO3, 0.1 mM EDTA). After centrifugation and
rinsing, the neutrophils isolated were resuspended in RPMI 1640
(Invitrogen) and kept on ice until the experiment.
Quantitative Real-Time PCR
Total RNA was isolated from AEC, BEAS-2B, or ADAM-12 trans-
fected clones. After treatment, cells were washed in sterile cold PBS,
snap-frozen, and stored at 2808 until RNA isolation by using TRIzol
reagent (Invitrogen) according to manufacturer’s instructions. RNA
concentration was determined by spectrophotometry and quality eval-
uated by electrophoresis through a 0.8% agarose gel visualized using
Gelstar staining, and capillar electrophoresis (2100 Bioanalyzer; Agilent
Technologies, Santa Clara, CA). For semi-quantitative RT-PCR, the
reaction was performed on 100 ng of total RNA using the GenAmp
thermostableRNART-PCRKit (AppliedBiosystems, FosterCity,CA).
ADAM-12 forward and reverse primers were designed as follows:
forward 59-TTGGCTTTGGAGGAAGCACAGA-39, reverse 59-TTG
AGGGGTCTGCTGATGTCAA-39 using the actin gene (see Table E1
in the online supplement for the primer sequence) as a reference to
normalize the quantity of mRNA in each sample. Samples were
separated by acrylamide gel electrophoresis and stained with Gel Star
(Cambrex, Verviers, Belgium).
Retro-transcription and quantitative real-time PCR were performed
using SuperScript Platinum SYBR Green Two-Step qRT-PCR Kit with
ROX (Invitrogen) according to manufacturer’s instructions. To obtain
a normalized target value, actin gene was used as control. Forward and
reverse primers for ADAM-10, -12, and -17, CXCL1, CXCL2, CXCL5,
CD47 and actin (used as a reference) were designed with Primer
Express software (Applied Biosystems). Their sequences were reported
in Table E1.
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Results were expressed as the mean 6 SEM of net gene expression
(DCtgene of interest 2 DCtactin) or relative gene expression expressed in
folds (22(DDCt)) compared with unstimulated cells used as calibrator.
Flow Cytometry Analysis
Epithelial layer of cultured confluent clones was dissociated with PBS 1
EDTA (5 mM) solution and cells were detached by scraping. Epithelial
cells were centrifuged and resuspended in PBS plus 2% fetal calf
serum. After permeabilization with the Perm-Wash kit (BD Bioscien-
ces, San Diego, CA) or not, cells were incubated with rabbit IgG anti–
ADAM-12 (N-terminal domain) or normal rabbit IgG (2 mg/ml;
Abcam). After washing, antibody binding was detected with phycoer-
ythrin (PE)-conjugated goat IgG anti-rabbit IgG (Invitrogen). Con-
cerning the adhesion molecules, the following mAb were used:
fluoresceine (FITC)-conjugated anti-CD49c (a3-integrin, clone 17C6;
ABD Serotec, Oxford, UK), PE-conjugated anti-CD29 (b1-integrin,
clone MAR4), anti-CD54 (ICAM-1, clone HA58), PE-Cy5–conjugated
anti-CD49 d (a4-integrin, clone 9F10) and unlabeled anti-CD49f (a6-
integrin, clone NKI GOH3; BD Biosciences), anti-CD51 (av-integrin,
clone AV1), and anti-CD104 (b4-integrin, clone ASC3; Chemicon,
Temecula, CA) mAb and the corresponding isotype controls. Mouse
IgG mAb anti-SIRPa (SE7C2; Santa Cruz Biotechnology, La Jolla,
CA), anti-CD47 (clone B6H12; BD Biosciences) and anti-EGFR
(MAB126; Chemicon) were also used in this study. Binding of un-
labeled mAb was detected by addition of PE-conjugated anti-mouse or
anti-rat IgG rabbit IgG (Southern Biotechnology, Birmingham, AL).
Then, cells were washed, fixed with paraformaldehyde (PFA) in PBS,
and 5,000 events were analyzed on a FACScalibur flow cytometer with
CellQuest software (Becton Dickinson, Pont de Claix, France). Results
are expressed as the difference between median fluorescence intensity
(MFI) with specific antibody minus the isotype control MFI (DMFI).
Chemokine Measurement
The concentration of human CXCL8/IL-8 and CXCL1/GRO-a was
determined in clone cell supernatants collected after 8 hours or 24 hours
by sandwich enzyme-linked immunosorbent assay (R&D Systems,
Abingdon, UK) as described by the manufacturer. Protein content of
cell lysates was determined using the Bradford method (Bio-Rad,
Hercules, CA) and results were expressed as pg/mg of total protein when
necessary.
ADAM-12 Transfected Clones Adhesion and Migration Assay
To assess ADAM-12 transfected clones adhesion, 96-well plates coated
with collagen G (Biochrom) or fibronectin (2.5mg/cm2; Sigma) as
substrates were preincubated with bovine serum albumin (0.5% in PBS
for 30min).BV27,BA17 andBA36 cloneswere plated for 1 hour at 378C.
After rinsing with PBS, the number of adherent cells was quantified by
MTT assay (Roche, Penzberg, Germany) according to the manufac-
turer’s instructions. Optical density was read at 570 nm. Results are
expressed as the mean6 SEM of number of adherent cells.
We evaluated the ADAM-12 transfected clones ability to migrate by
Wound Healing Assay. For this, confluent clones grown onto collagen
G or fibronectin-coated plates were scratch wounded and pictures were
taken at 0, 12, 24, 36, and 48 hours. Wound healing rate was determined
by quantifying the cell-free surface inside the wound. Results are
expressed as the percent of cell-free surface at each time point,
considering the time point 0 as 100%.
Neutrophil Chemotaxis, Adhesion, and Migration Assays
Chemotaxis was performed in 48-well Boyden microchamber
(NeuroProbe, Gaithersburg, MD). The lowest well was filled with
supernatant from clones (1/10 in RPMI medium), recombinant human
CXCL8 (200 ng/ml; R&D Systems) or with medium (RPMI 1640;
Invitrogen). Each condition was performed in triplicate. The chamber
was covered with a polycarbonate membrane of a 3-mm pore size.
Then, neutrophil suspension in RPMI 1640 (45 ml at 1 3 106 cells/ml)
was added to each well of the upper chamber. After incubation for
30 minutes at 378C, cells that passed trough the membrane were fixed in
methanol and stained with May Gru¨nwald Giemsa. Membranes were
mounted and four fields per well were counted. Neutrophil chemotactic
activity is expressed as mean neutrophil number observed for each
clones supernatant condition minus the mean neutrophil number ob-
served from RPMI alone condition. To define the implication of
chemokines in neutrophil recruitment, we preincubated for 1 hour,
supernatants from BA clones or as a control, CXCL1 and CXCL8
solution at 100 ng/ml with neutralizing monoclonal antibodies against
human CXCL1 and CXCL8 (10 mg/ml; R&D Systems).
To test the neutrophil adhesion, clones were seeded in a 96-well plate
until confluence. Purified neutrophils resuspended in HBSS (Hanks’
balanced salt solution; Invitrogen) were added either onto clones (2 3
105 per well or at growing known concentrations) or onto plastic plates
and incubated for 1 hour at 378C. In the case of attachment to plastic,
HBSS or supernatants collected from clones (stimulated or not with
20 ng/ml TNFa for 1 h) were added to neutrophils. After incubation,
plates were rinsed in PBS and cells were lysed in LBH and then frozen
and thawed twice. The number of adherent neutrophilswas quantifiedby
their peroxydase activity with OPD (o-Phenylenediamine dihydrochlor-
ide; Sigma). Results are expressed as numbers of neutrophils that
remained attached. To rule out the possibility that ADAM-12 could
cleave the CD47 receptor SIRP-a (SIRP-1) present on neutrophils, we
measured its membrane expression after neutrophil adhesion onto
BEAS-2B cells or ADAM-12–overexpressing clones (stimulated or not
with 20 ng/ml TNF-a). Quantification was performed by flow cytometry
as described above using a mouse IgG mAb anti–SIRP-a (Santa Cruz
Biotechnology).
Migration assays were performed using 3-mm-pore Transwell inserts
that were coated on the lower side with collagen G. Clones were loaded
onto this side, and after they reached confluence, theywere stimulated or
not with TNF-a (20 ng/ml; Peprotech) added in the lower chamber.
Purified neutrophils in HBSS (1 3 106) were loaded on the upper
chamber and incubated for 1 or 2 hours at 378C. After incubation,
neutrophils were recovered from loading compartment, which contains
cells that did not migrate, from epithelial cells layer and from the lower
chamberwith neutrophils thatmigrated.Aknownnumberof neutrophils
followed the same process to be used as reference. After lysis in LBH,
cells were frozen and thawed twice and loaded onto a 96-well plate for
detection. The number of neutrophils was quantified by their peroxydase
activity with OPD (o-Phenylenediamine dihydrochloride; Sigma).
Results are expressed as the % of neutrophils that migrated toward the
lower chamber from the total of neutrophils recovered.
Statistical Analyses
Statistical analysis was performed with Graph Pad Prism 4.03. Pop-
ulation differences were evaluated by two-sided Student’s t test or for
multiple comparisons, one-way ANOVA followed by Turkey test, or
Kruskal-Wallis Test followed by Dunn’s Multiple Comparison Test
when corresponded, according to the experiment and to the distribu-
tion of the data. Results are expressed as mean6 SEM. A P, 0.05 was
considered significant and P , 0.001 to be highly significant.
RESULTS
ADAM-12 Expression Is Increased in Airway Epithelial Cells by
Allergen Challenge in Patients with Allergic Rhinitis
ADAM-12 productionwas evaluated in nasal biopsy sections from
patients with allergic rhinitis or from control subjects obtained at
baseline and after allergen challenge. In contrast to control
subjects, patients with allergic rhinitis developed a dual clinical
response and inflammation within nasal tissue. At baseline, the
expressionofADAM-12wasdetectableby immunohistochemistry
in the upper layer of AEC both in control subjects and in patients
with allergic rhinitis, and no difference was detected between both
groups (Figures 1Aand1C, respectively).After allergenchallenge,
an increaseofADAM-12 synthesis inAECwasobserved incontrol
subjects (Figure 1D) (10.96 1.5 and 24.76 2.6%of positiveAEC,
beforeandafter allergen challenge, respectively).For patientswith
allergic rhinitis, a strong increase of ADAM-12 expression was
observed in the different layers of AEC (21.1 6 1.7 and 59.5 6
12.7% of positive AEC, before and after allergen challenge,
respectively) and also in some vascular sections (Figures 1E and
1F). No stainingwas detectedwith the isotype control (Figure 1B).
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Cytokines Modulate ADAM-12 Production in Bronchial
Epithelial Cells and in ADAM-12–Overexpressing Clones
To identify the potential factors implicated in ADAM-12 over-
expression during the allergic reaction, we measuredmRNA and
protein expression in primary culture of AEC or BEAS-2B cell
line in the presence of TNFa, IL-4 and IL-13. Treatment with
TNF-amarkedly enhanced themRNAexpression forADAM-12
in AEC primary culture, with a maximal activity at 24 hours
(Figure 2A). Similar results were obtained in BEAS-2B cells.
Quantification of the mRNA performed by qRT-PCR revealed
that TNF-a stimulation at a dose of 20 and 50 ng/ml for 24 hours
enhanced by 3- to 4-folds the mRNA expression for ADAM-12
(Figure 2B, P , 0.01 versus unstimulated cells). Moreover, IL-4
and IL-13 (Figure 2B) but not IFN-g (data not shown) amplified
the effect of TNF-a, whereas alone, they did not significantly
enhance the ADAM-12 expression. In parallel, we tested the
modulation of other HB-EGF sheddases (ADAM-10 and -17)
in AEC. Our data revealed that activation by these cytokines
did not modulate the mRNA expression of both metallopro-
teases (Figure E1A). Evaluation by flow cytometry after in-
tracellular immunostaining showed that 24 hours of incubation
withTNF-a also increasedADAM-12 synthesis (Figure 2C,P,
0.05).
To define the effect ofADAM-12 overexpression, we selected
ADAM-12–overexpressing clones (termedBA17 andBA36) and
the control clone transfected with empty vector termed BV27,
which were previously characterized (18). At baseline, ADAM-
12mRNAexpression inBA17andBA36was 20 times higher than
in the control clone (18) (P , 0.001; Figure 2D). Nevertheless,
activation by TNF-a enhanced the mRNA level in BV and BA
cloneswith a difference of approximately 2 to 3 times (P, 0.001).
Protein expression was also enhanced with the same range in BA
clones compared with BV27 (not shown). There is no difference
between the BV27 clone and the BEAS-2B cells concerning the
expression of ADAM-12 either at baseline or after activation
with TNF-a (data not shown). The ADAM-10 and -17 mRNA
expression was similar at baseline in BA17 and BA36 clones as
compared with BV27 and BEAS-2B cells, and did not change
after stimulation with TNF-a (Figure E1B).
ADAM-12 Overexpression Regulates Integrin Expression and
Epithelial Cell Adhesion and Migration
We first evaluated the expression of integrins and the cell
adhesion to extracellular matrix (ECM) components in unstimu-
lated and in TNF-a–activated clones. As shown in Figure 3A,
overexpression of ADAM-12 gene significantly increased the
expressionofa3 anda4 integrins in both conditions. IntegrinsaV,
a6, b1, b3, and b4 were also measured, and no modulation was
observed (data not shown).
Cell adhesion to collagenGand to fibronectin was determined
for clones. As shown in Figure 3B, clones BA17 and BA36
Figure 1. A Disintegrin and Metalloprotease (ADAM)-12
expression in nasal biopsies from (A and D) healthy
individuals and (B, C, E, and F ) allergic patients before
(A, C ) and after exposure to the allergen Dpt (B, D–F ).
Positive staining was detected in red and sections were
counterstained with hematoxylin. ADAM-12 expression in
epithelial cells (black arrows) and vascular wall (asterisks)
was increased in allergic patients after allergen challenge
compared with control subjects. No staining was detected
with the nonimmune rabbit IgG (B); (magnification:
3500).
Figure 2. ADAM-12 mRNA expression is increased in airway epithelial
cells (AEC) after stimulation. (A) AEC primary culture stimulated for 2,
6, or 24 hours with TNF-a were analyzed by semiquantitative PCR. (B)
Expression of ADAM-12 mRNA in BEAS-2B cell line detected by
quantitative RT-PCR after 24 hours of stimulation with TNF-a, IL-4, or
IL-13. qRT-PCR results are expressed in folds versus nonstimulated
control corresponding to the value of 1. Bars represent the mean 6
SEM (n 5 5), **P , 0.01; ***P , 0.001 compared with CTR (cells in
medium alone). (C ) Flow cytometry analysis of ADAM-12 in BEAS-2B
after 24 hours of stimulation with TNF-a. Bars show the mean 6 SEM
(n 5 4) of the difference between median fluorescence intensity with
the specific antibody minus the isotype control MFI (DMFI). *P , 0.05
compared with CTR. (D) ADAM-12 mRNA expression in BA and BV
clones in CTR and after 24 hours of stimulation with TNF-a. Bars
represent the mean 6 SEM (n 5 5), ***P , 0.001 compared with BV27
CTR; xxxP , 0.001 versus BA17 and BA36 CTR.
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displayed a reduced adhesion to fibronectin as compared with
BV27 clone, but the difference was significant only for BA36
(Figure 3B, P , 0.01).
To complete this approach, kinetics of cell migration in
a wound-healing assay was determined for these clones on the
same ECM components. Our data showed that the stripped
surface was almost totally covered after 48 hours of incubation
in BV27 cells as well as in BA clones (Figure 3C) and BEAS-2B
cells (data not shown) cultured on collagen G. Onto fibronectin,
the wound healing for BV27 clones was incomplete at 48 hours,
remaining at approximately 30% of cell-free surface, whereas it
was approximately at 15% in both BA clones (Figure 3C).
These data show that the up-regulation of ADAM-12 in
bronchial epithelial cells leads to an increased expression of
certain a-integrins and to the modulation of cell attachment and
migration on fibronectin but not on collagen G.
ADAM-12 Overexpression Increases CXCL1 and CXCL8
Secretion and Neutrophil Recruitment
An important function of AEC is to control the local inflamma-
tory reaction through its response to danger signal by secreting
chemokines such as CXCL8 able to induce granulocyte recruit-
ment (27). To assess potential involvement of ADAM-12 in this
process, we first focused on CXCL8 secretion by BA clones. As
shown inFigure 4A,CXCL8was enhanced in unstimulatedBA36
compared with the control clone BV27 (P , 0.05). A similar
tendencywas observed inTNF-a–activatedBEC (Figure 4A). To
define the implication of other chemokines active on neutrophils,
the expression of CXCL1, CXCL2, and CXCL5 was first evalu-
ated by qRT-PCR. While CXCL2 and CXCL5 were not modu-
lated, themRNA expression for CXCL1 was markedly increased
in BA clones in comparison to BV27 cells (3-fold increase; data
not shown). At the protein level, the secretion of CXCL1 was
increased in unstimulated (P, 0.05) and TNF-a–activated (P,
0.05 only for BA17 cells) BA17 and BA36 clone in comparison
with BV27 cells in the same culture condition (Figure 4A).
We also measured the chemotactic effect of these super-
natants on neutrophils. Supernatants were obtained after 24
hours of incubation of clones under control or TNF-a stimula-
tion. As expected, TNF-a activation of BV27 clone increased
the number of recruited neutrophils in comparison with unsti-
mulated condition. Supernatants of unstimulated and TNF-
a–activated BA17 and BA36 clones collected at 24 hours
induced an increase of neutrophil recruitment (Figure 4B, P ,
0.05 for BA17) compared with BV cells. To determine the role
of CXCL1 and CXCL8 in this effect, we preincubated the
supernatants of BA clones with neutralizing anti-CXCL8 and
anti-CXCL1 antibodies. Neutralization of CXCL8 did not
affect the neutrophil recruitment induced by the clones (20%
decrease), whereas this treatment inhibited the effect of
rh-CXCL8 (78.8% decrease). In contrast, neutralization of CXCL1
significantly decreased the effect of BA17 and BA36 clones by
52%, and it diminished the rh-CXCL1 activity by 72%.
These data show that ADAM-12 overexpression in BEAS-
2B cells increases the secretion of CXCL1 and CXCL8 as well
as the capacity to recruit neutrophils. Our data strongly suggest
that CXCL1 has a major role in this activity in contrast to
CXCL8.
ADAM-12 Overexpression Modulates CD47 Expression,
Neutrophil Adhesion, and Transepithelial Migration
The transepithelial migration of neutrophils is a multi-step pro-
cess that involves different adhesion molecules expressed by
epithelial cells, such as ICAM-1 and the integrin-associated
protein CD47. To elucidate the mechanism of ADAM-12 action
Figure 3. ADAM-12 overexpression modulates integrin expression and
cell adhesion and migration. (A) Flow cytometry analysis of a3 integrin
and a4 integrin protein expression in ADAM-12–overexpressing clones
in CTR and after 24 hours of stimulation with TNF-a. Graphs show the
mean 6 SEM of DMFI (n 5 10), *P , 0.05 versus BV27. (B) Cell
attachment to collagen or fibronectin matrix is reduced in ADAM-12–
overexpressing clones (n 5 7), **P , 0.01 BA36 versus BV27. (C )
Wound Healing Migration Assay onto collagen or fibronectin sub-
strates. Plots show the mean 6 SEM of the % of ADAM-12 clones-free
surface at different time points (n 5 5).
Figure 4. (A) CXCL1 and
CXCL8 secretion from super-
natants of clones stimulated or
not with TNFa for 24 h de-
termined by enzyme-linked
immunosorbent assay (ELISA).
Values represent the mean 6
SEM (n 5 4–6), *P , 0.05 and




lated or not with TNF-a for
24 hours was determined after
migration in a micro-chemo-
taxis chamber. Values repre-
sent the mean 6 SEM of the
number of neutrophils mi-
grated (n 5 5), *P , 0.05
versus respective BV27.
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on neutrophil recruitment, we measured the levels of ICAM-1
and CD47 expression in clones overexpressing ADAM-12. As
expected, treatment with TNF-a significantly enhanced the
membrane expression of ICAM-1 in all clones (P , 0.001),
although its level was similar in BA and BV clones in either
unstimulated or in TNF-a–activated cells (Figure 5A). In con-
trast, CD47 membrane expression and mRNA levels were
significantly lower in BA clones compared with BV27 or to
BEAS-2B cells at baseline (Figure 5B, P , 0.01 and P , 0.05,
respectively). TNF-a stimulation significantly increased CD47
protein and mRNA expression in BA clones (Figure 5B, P ,
0.05). It has been previously observed that the interaction
between epithelial CD47 and its counterreceptor signal regula-
tory protein (SIRP-a) regulates adhesive signaling processes (28)
and enhances the rate of transepithelial migration of neutrophils
(29). Considering this, we determined the ability of neutrophils to
attach to clones and to migrate through a confluent epithelium.
ADAM-12 overexpression led to an inhibition of neutrophil
attachment to these cells compared with BV27 (Figure 5C, P ,
0.05). To rule out the possibility that ADAM-12 might shed the
extracellular domain SIRPa on neutrophils and thus contribute
to regulate CD47–SIRPa interaction, we measured the expres-
sion of SIRP-a in neutrophils by flow cytometry after a neutrophil
adhesion assay onto AEC. We observed that incubation of
neutrophils with BEAS-2B cells significantly enhanced mem-
brane SIRP-a expression (P , 0.01; Figure E2). However, the
level of SIRP-a on granulocytes incubated with BA17 and BA36
clones was not significantly different from that observed in
presence of BEAS-2B or in BV27 cells.
Analysis of neutrophil transepithelial migration in Transwell
inserts showed that TNF-a stimulation for 1 (Figure E3) and
2 hours increased migration at similar levels in all clones, with
a maximal effect at 2 hours (Figure 5D). However, the number
of neutrophils migrating through the unstimulated confluent
epithelium of BA clones was slightly reduced as compared with
BV27 (P 5 NS).
Our results indicate that ADAM-12 overexpression in
epithelial cells decrease neutrophils attachment to BA clones
and decrease CD47 expression, which can possibly affect trans-
epithelial passage.
ADAM-12 Overexpression Mediates the CXCL1, CXCL8, and
CD47 Expression via EGFR
Considering that one of the well-known functions of ADAM-12
is the shedding of the EGFR ligand Pro HB-EGF (17), and that
secretion of mature HB-EGF was increased in BA as compared
with BV clones (18), we tested the hypothesis that ADAM-12
affects the epithelial functions through the transactivation of
this receptor.
For this purpose, we determined the membrane expression
of EGFR in clones. We found that EGFR expression in BA or
BV clones or BEAS-2B did not vary in either unstimulated or
TNF-a–stimulated conditions (Figure 6A and data not shown).
We analyzed the capacity of the EGFR inhibitor AG1478 to
reverse the effects of ADAM-12 overexpression. Treatment of
the clones with AG1478 during 24 hours did not affect the
increased expression of a3 and a4 integrins previously observed
(Figure 6B). In contrast, AG1478 markedly inhibited the synthe-
sis of CXCL1 and CXCL8 byBA17 (P, 0.05) or BA36 (P5NS)
clone (Figure 6C), whereas it had no effect on BV27 cells.
However, AG1478 did not reverse the inhibitory effect of
ADAM-12 overexpression on CD47 protein expression (Figure
6D).
We also measured the effect of EGF on the same parameters
in BEAS-2B cells. The a3-integrin expression was significantly
increased afterEGF stimulation (Figure 7A,P, 0.05). This EGF
effect was totally blocked by pre-treatment with the EGFR
inhibitor AG1478 (P , 0.05; Figure 7A). Conversely, no signif-
icant effectwas observed for the expressionofa4-integrin (Figure
7A). The addition of EGF to BEAS-2B cells strongly up-
regulated CXCL1 and CXCL8 levels (Figure 7B, P , 0.05 and
P , 0.001, respectively) and the inhibitor AG1478 neutralized
this effect (Figure 7B, P , 0.01 and P , 0.001, respectively).
CD47 expression was significantly inhibited after stimulation
with EGF (Figure 7C,P, 0.05), whereas the addition ofAG1478
plus EGF significantly increased its expression (Figure 7C, P ,
0.001).
In summary, ADAM-12 overexpression probably induced
EGFR transactivation, which is implicated at least in part in the
regulation of a3 integrin and CD47 expression as well as in
CXCL1 and CXCL8 production.
DISCUSSION
In this study we report that ADAM-12 expression is strongly
increased in airway epithelial cells from patients with allergic
rhinitis after allergen challenge. In vitro, TNF-a stimulation also
induces the up-regulation of ADAM-12 in AEC and BEAS-2B
cells. Based on these results, we analyzed the effect of ADAM-12
overexpression on AEC functions. Our data show that AEC
transfection with a plasmid expressing ADAM-12 affects the
expression of integrins, cell adhesion, and migration, as well
Figure 5. (A) ICAM-1 protein expression analyzed by flow cytometry in
BA and BV clones after 24 hours of stimulation with TNF-a. Graphs
report the mean 6 SEM of DMFI (n 5 4–6), ***P , 0.001 versus CTR.
(B) CD47 protein expression analyzed by flow cytometry and CD47
mRNA expression determined by real-time quantitative qRT-PCR in
clones after stimulation with TNF-a for 24 hours; *P , 0.05 and **P ,
0.01 versus BV27 CTR; xP , 0.05 versus BA17 and BA36 CTR. (C ) Effect
of ADAM-12 overexpression on neutrophil adhesion onto clones. Graph
shows the mean 6 SEM of the numbers of neutrophils that remained
attached after 1 hour of incubation (n 5 4), *P , 0.05 versus BV27. (D)
Neutrophil transepithelial migration through a confluent epithelium of
BA and BV clones activated or not by TNF-a for 2 hours. Bars represent
the mean 6 SEM of the percent of neutrophils that migrated from total
recovered in all compartments (n 5 4).
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as their capacity to secrete chemokines and to recruit neutro-
phils.
Allergen exposure of patients with allergic rhinitis increases
the production of ADAM-12 in nasal epithelium and endothe-
lium. Since we demonstrated a direct effect of TNF-a on AEC,
TNF-a may be implicated in the increased expression of this
metalloprotease during the allergic reaction (23, 24), Interest-
ingly, the Th2 cytokines IL-4 and IL-13 amplify the ADAM-12
expression induced by TNF-a in airway epithelium, probably
explaining the enhanced level observed in the patients with
allergic rhinitis. Since these cytokines are involved in allergic
asthma (1) and affect the production of ADAM-12 in primary
culture of bronchial epithelial cells, allergic asthma is probably
associated with an increased synthesis of this metalloprotease.
Another argument is raised by the fact that an increased
expression of ADAM-12 mRNA was detected in induced
sputum from patients with allergic asthma (10).
Our goal was then to determine the consequence of ADAM-
12 overexpression in AEC. We previously showed that cells
overexpressing ADAM-12 display increased proliferation rates
and are protected against etoposide-induced apoptosis (18). In
the present study, we have first analyzed the consequences of
ADAM-12 overexpression on cell migration and adhesion. In
contrast to b integrins, a3 and a4 integrins were significantly
overexpressed on cell membranes by the up-regulation of
ADAM-12, although no effect was detected at the level of
mRNA expression (data not shown). Therefore, these results
are in agreement with the concept of ADAMs affecting the
surface localization of integrin (19). It has been shown that a3/
b1 and a4/b1 integrins bind to the major constituents of the
basal membrane like collagen and to ECM proteins such as
fibronectin, which are found to be increased during inflamma-
tion (30). Adhesion experiments showed that ADAM-12–
overexpressing clones adhere with a lower intensity onto
fibronectin. Considering that b1 integrin levels were not mod-
ified, these results indicate that a3 and a4 might not have
a major role in the cell adhesion onto this substrate. Another
hypothesis is that the increased membrane expression of these
integrins was not associated with an increased functionality.
Moreover, it has been reported that ADAM-12 expression can
moderately increase cell adhesion to fibronectin, although this
effect is not specific to a4/b1 integrin (31). Whether ADAM-12
up-regulation also affected the expression of surface glycopro-
teins involved in adhesion to fibronectin remains to be de-
termined. Interestingly, re-epithelialization in a wound healing
assay was slightly faster onto fibronectin matrix in ADAM-12–
overexpressing clones. Some possible explanations include in
one hand, the increase in proliferation rate and on the other
hand, the modulation of integrin expression. The fact that
ADAM-12 increases cell proliferation suggests that its effect
on re-epithelialization may be due to an accelerated cell
division (18). Moreover, in vivo, re-epithelialization depends
on rapid migration of epithelial cells over the injured area (31,
32) and on the expression of a2, a3, and a6 integrins (33).
Interestingly, ADAM-12 overexpression increased the level of
a3 integrin, which can selectively influence cell migration.
During lung inflammation, airway epithelial cells produce
several interleukins and chemokines leading to leukocyte re-
Figure 7. Modulation by EGFR activation of BEAS-2B cell function. (A)
Flow cytometry analysis of a3 integrin and a4 integrin protein
expression after 24 hours of stimulation with EGF, AG1478, or both
EGF and AG1478. Graphs show the mean 6 SEM of DMFI (n 5 7), *P ,
0.05 versus CTR and xP , 0.05 versus EGF. (B) CXCL1 and CXCL8
secretion determined in cell supernatants in the same conditions as
described in A. Values represent the mean 6 SEM (n 5 5–9), *P , 0.05
and ***P , 0.001 versus CTR; xxP , 0.01 and xxxP , 0.001 versus EGF.
(C ) CD47 protein expression analyzed by flow cytometry in BEAS-2B
cells incubated in the same conditions as described in A. Graph shows
the mean 6 SEM of DMFI (n 5 6), *P , 0.05 versus CTR and xxxP ,
0.001 versus EGF.
Figure 6. (A) Epidermal growth factor receptor (EGFR) protein levels
analyzed by flow cytometry after 24 hours of stimulation with TNF-a.
Data are expressed as the mean 6 SEM of DMFI (n 5 4). (B) a3 and a4
integrins and (D) CD47 protein expression analyzed by flow cytometry
after 24 hours of treatment with AG1478 of unstimulated and TNF-
a–activated clones. Bars show the mean 6 SEM of DMFI (n 5 4–5),
*P , 0.5 and **P , 0.01 versus BV27 CTR. (C ) CXCL1 and CXCL8
secretion determined by ELISA in cell supernatants from clones in the
same conditions as reported in B. Values represent the mean 6 SEM
(n 5 4), *P , 0.01 versus CTR and **P , 0.01 versus BV27.
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cruitment toward the site of injury (27, 34). At baseline and in
TNF-a–stimulated conditions, bronchial epithelial cells over-
expressing ADAM-12 secrete higher levels of CXCL1 and
CXCL8 associated with an increased recruitment of neutrophils.
As shown by neutralization experiments, CXCL8 is not mainly
involved in the modulation of neutrophil migration, whereas
CXCL1 plays an essential role at least in vitro.We cannot exclude
that in vivo, CXCL8or other chemoattractantsmay interferewith
CXCL1. In addition, BA clones secreted significantly higher
levels of CCL5/RANTES involved in the recruitment of mono-
cytes, T cells, and eosinophils (data not shown). Neutrophil
transepithelial migration requires the involvement of adhesion
molecules, including ICAM-1 and CD47, to facilitate neutrophil
attachment and migration (35). ICAM-1 protein is up-regulated
in airway epithelium in response to inflammatory mediators (36)
and localizes at the apical region of cell boundaries (37). Under
these conditions, the migrating front of a neutrophil within the
epithelial paracellular space binds to ICAM-1 (29). However,
there was no difference in ICAM-1 expression between BA and
BV clones, although TNF-a stimulation induced a significant
increase of ICAM-1 expression. Whether ADAM-12 is impli-
cated in its redistribution within the epithelium remains to be
determined.
CD47 is a penta-transmembrane protein highly expressed in
most cell types, including epithelial cells. It colocalizes with E-
cadherin and ZO-1 at cell–cell adhesion sites and participates to
the regulation of cell adhesion and migration through reorgani-
zation of the actin cytoskeleton (38). During leukocyte trans-
migration, CD47 regulates the rate of PMN transepithelial
migration but does not affect initial adhesion events (35, 39).
In vitro, PMNmigration across epithelial cell monolayers deficient
in CD47 was significantly increased after stable transfection with
CD47 (39). Although the mechanisms of how CD47 regulates
neutrophils transepithelialmigration andepithelial cell responses
during transmigration are not elucidated (29), it is known that
CD47 associates with a number of molecules, including some
integrins and signal regulatory protein (SIRP)a (SHP substrate-1
or SHPS-1) (39). SIRPa, which is present at high levels on
neutrophils (28, 40), facilitates the neutrophil progression toward
the paracellular space (35).Here, we observed that the number of
neutrophils that adhere to ADAM-12–overexpressing cells was
significantly decreased. This effect was not due to soluble factors
because the incubation of neutrophils with supernatant from
ADAM-12–overexpressing clones aloneor collected afterTNF-a
stimulation had no effect (data not shown). Interestingly, in
ADAM-12–overexpressing cells, CD47 membrane expression
and mRNA levels are significantly down-regulated. In addition,
the ectodomain shedding of SIRPa is required for cell migration
(41) and is blocked by a metalloprotease inhibitor KB-R7785,
which has been shown to neutralize ADAM-12–mediated ecto-
domain cleavage of HB-EGF (17). Nevertheless, neutrophil
coculture with BA17 and BA36 clones does not reduce the
membrane expression of SIRP-a in neutrophils, suggesting that
thismetalloprotease is not involved in the shedding of SIRPa.We
also observed that the up-regulation of ADAM-12 induced
a decrease in neutrophils transepithelial migration in unstimu-
lated conditions, but not after activation with TNF-a. This can be
related with the fact that CD47 expression is markedly inhibited
in unstimulated BA clones, but is strongly increased after
stimulation with this cytokine, although there is still some
difference as compared with the BV clones.
Together these results suggest that overexpression of
ADAM-12 in AEC increases their neutrophil chemotactic
activity, alters their capacity to effectively attach neutrophils,
and can lead to a decrease of the transepithelial passage of these
latter probably due to the low levels of CD47. Thus, ADAM-12
may target the regulation of initial steps of neutrophil trans-
epithelial migration, adhesion, and migration itself preventing
the passage into the paracellular spaces. This negative regula-
tion may be a way to control the PMN rate of access to the
epithelium-lumen and may lead to their accumulation within
the airway mucosa.
Because we previously found that the BA clones produce high
levels of mature HB-EGF (18), we considered a possible in-
volvement of EGFRactivation. It has previously been shown that
AEC expressed major HB-EGF sheddases, such as ADAM-10
and ADAM-17 (42, 43). Although at baseline the ADAM-12
expression is low compared with ADAM-10 and -17 mRNA
levels, ADAM-12 expression is strongly up-regulated in vitro by
TNF-a. Soluble HB-EGF production by BA clones is approxi-
mately 5- to 10-fold increased in comparison to BV27 or BEAS-
2B cells (18) demonstrating that a 20-fold increase in the level of
ADAM-12 is associated with a very significant increase in the
level ofHB-EGF. It is also important to underline that the level of
ADAM-9 (18), ADAM-10, and ADAM-17 are not differentially
expressed inBA17 andBA-36 clones as comparedwithBV27 and
BEAS-2B cells. These data suggest that theTNF-a– and allergen-
induced up-regulation ofADAM-12might be associatedwith the
HB-EGF–mediated EGFR activation. As previously demon-
strated, the stimulation of airway epithelial cells with TNF-a
causes EGFR expression (44), but the EGFR membrane levels
are not increased in BA clones as compared with BV27. By using
a pharmacologic inhibitor specific for EGFR, we demonstrated
that the increased secretion of CXCL1 and CXCL8 observed in
ADAM-12–overexpressing clones was reversed, while a3 and a4
integrins and CD47 were not affected. Using BEAS-2B cells, we
show that the stimulation with EGF reproduced the modulation
of 2- to 3-fold of a3 integrin expression, secretion of CXCL1 and
CXCL8, and CD47 membrane expression observed in ADAM-
12–overexpressing clones. This effect was reverted by the EGFR
inhibitor AG1478 in the case of CXCL1 and CXCL8 confirming
the implication of EGFR in the effect of ADAM-12. Previous
reports have shown that EGFR transactivation leads to CXCL8
secretion through the mobilization of EGFR/ERK1/2/activating
protein-1 pathway (45). Interestingly, AG1478 also blocked the
EGF-induced modulation of a3 integrin and CD47. Taking into
account the presence of high levels of HB-EGF secreted by
ADAM-12–overexpressing clones, it seems highly probable that
EGFR receptor is activated by this ligand in BA clones. To
explain the discrepancy concerning the a3 integrin and CD47
expression, one might speculate that different pathways are
mobilized by ADAM-12 and that the inhibition of EGFR is not
sufficient to stop the expression of both molecules. Moreover,
considering that we focused on the pharmacologic inhibition of
EGFR, it is possible that other receptors, such as erbB4, might be
involved in this regulation. Another possibility is that a3 integrin
and CD47 expression is less dynamically regulated than the
secretion of chemokines, and that the duration of the treatment
withAG1478 is not sufficient toobtain a significant effect on these
parameters.
Together, these results showed that allergic inflammatory
reaction is associated with the production of ADAM-12 within
the airway epithelium. The overexpression of ADAM-12 is
responsible for the modulation of cell adherence and migration.
Moreover, this process is likely to participate in granulocyte
recruitment through the production of chemokines and the
regulation of adhesion molecules, potentially leading to the
accumulation of neutrophils within the airway mucosa. Thus,
these data show that ADAM-12 by the modulation of neutrophil
migration associated with the transactivation of EGFR may
participate in the airway remodeling associated with the allergic
reaction.
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